Thyrocare Technologies share price
You have to be logged in to add this to Watchlist.- ₹420.40(2.36%)December 8, 2025 15:29:30 PM IST
- NSE
- BSE
- Vol : 1.02 M (NSE + BSE)Last 20 day avg : 1.41 M
Thyrocare Technologies is trading 2.36% upper at Rs 420.40 as compared to its last closing price. Thyrocare Technologies has been trading in the price range of 425.00 & 409.00. Thyrocare Technologies has given 34.91% in this year & -17.28% in the last 5 days. Thyrocare Technologies has TTM P/E ratio 47.77 as compared to the sector P/E of 26.97.There are 2 analysts who have initiated coverage on Thyrocare Technologies. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 47.99 Crores in its last quarter.Listed peers of Thyrocare Technologies include Aster DM Healthcare (-2.61%), Fortis Healthcare (-3.34%), Apollo Hospitals Enterprise (-1.39%).The Mutual Fund holding in Thyrocare Technologies was at 11.89% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Thyrocare Technologies was at 4.85% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 08, 2025, 11:48 PM UTC
- BetaLow volatility0.69Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.28Annual dividends as a percentage of the stock price.
- P/BHigher than historical values11.92The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values50.77Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-2.58The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aster DM Healthcare | Moderately Bearish | 618.55 | -2.61 | 32,043.20 | 95.11 | 9.49 | 0.77 | 53.36 |
| Fortis Healthcare | Moderately Bearish | 858.20 | -3.34 | 64,925.79 | 78.79 | 7.52 | 0.11 | 25.92 |
| Apollo Hospitals Enterprise | Bearish | 7,089.05 | -1.39 | 1,01,875.81 | 71.38 | 12.61 | 0.26 | 83.18 |
| Narayana Hrudayalaya | Bullish | 1,923.25 | 0.35 | 39,265.79 | 49.22 | 10.85 | 0.23 | 59.03 |
| Max Healthcare Institute | Bearish | 1,078.80 | -1.74 | 1,04,908.17 | 93.64 | 11.23 | 0.14 | 29.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-10-14 | Qtr Results, Int. Dividend & Bonus issue |
| 2025-07-23 | Quarterly Results |
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
- IndustryHealthcare Facilities
- ISININE594H01019
- BSE Code539871
- NSE CodeTHYROCARE
Thyrocare Technologies is trading at 420.40 as on Mon Dec 08 2025 09:59:30. This is 2.36% upper as compared to its previous closing price of 410.70.
The market capitalization of Thyrocare Technologies is 6718.97 Cr as on Mon Dec 08 2025 09:59:30.
The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Thyrocare Technologies is 537.97 whereas the 52 wk low is 219.33
Thyrocare Technologies can be analyzed on the following key metrics -
- TTM P/E: 47.77
- Sector P/E: 26.97
- Dividend Yield: 2.28%
- D/E ratio: 0.05
Thyrocare Technologies reported a net profit of 91.51 Cr in 2025.
The Mutual Fund Shareholding was 11.89% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Thyrocare Technologies QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.